Learning @ ISTM
Dengue: New Control Strategies
Recorded On: 06/28/2023
- Non-Member - Free!
- 5 Year Doctoral Level Member - Free!
- 5 Year Non-Doctoral Level Member - Free!
- Doctoral Level Members - Free!
- Associate Doctoral Level Members - Free!
- Retiree Doctoral Level Members - Free!
- Non-Doctoral Level Members - Free!
- Lifetime Retiree Doctoral Level Member - Free!
- Associate Non-Doctoral Level Members - Free!
- Retiree Non-Doctoral Level Members - Free!
- Lifetime Retiree Non-Doctoral Level Member - Free!
- Limited (Student/Trainee) Level Members - Free!
- Special Associate Member - Free!
- Staff/Administration - Free!
- Hon. Lifetime Member - Free!
Title: Dengue and Climate Change: Emerging Disease in Non-Endemic Regions
Date: Wednesday, 28th June 2023
Time: 9.00 EDT UTC-04 (The webinar is approximately 90 minutes)
To check your time zone, go to the time and date website: Here
You must register to attend. If you are not a member and wish to attend, you can create a free profile here, but membership is always encouraged as it is the most beneficial.
Dengue, the most common arboviral disease, continues to afflict large tropical and sub-tropical areas of the world, with outbreaks ongoing after the lifting of COVID-19 restrictions and population mobility. With climate change, urbanization, increasing population density and vector density, innovative control strategies are needed, whether through vector control and/or new vaccine development.Special thanks to Takeda for the unrestricted educational grant that helped provide this program.
PEC Incoming Chair: Dr. Yen Bui
Immediate Past President, ISTM: Dr. Lin Chen
Dr Francesca Norman
National Referral Unit for Tropical Diseases, Infectious Diseases Department,
Ramón y Cajal University Hospital, IRYCIS, Universidad de Alcalá, CIBER de Enfermedades Infecciosas, Madrid, Spain
Dr Tomas Jelinek
Medical Director, Berlin Center for Travel & Tropical Medicine, Germany
Scientific Director, Center for Travel Medicine, Düsseldorf, Germany
Associate Professor of Medicine, University of Cologne, Germany
Dr Anna Durbin
Professor, International Health Director, Center for Immunization Research
Johns Hopkins Bloomberg School of Public Health, USA
Dr Gabriela Paz-Bailey
Chief, Dengue Branch, Division of Vector Borne-Diseases Centers for Disease Control and Prevention, USA
By the end of this webinar, the attendee will be able to:
1. Identify the most promising vector control strategies
2. Discuss the efficacy and safety of the main vaccines in development
3. Recognize populations at risk, including travelers, who would most benefit from these vaccines
Who Should Attend:
- Travel Health practitioners - Doctors, Nurses, and Pharmacists
- Public Health practitioners and policy makers
- Military Medicine personnel
- Any others who care for travelers or expatriates